| Name | Walgreens #15974 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 43 N Front St, Central Point, Oregon 97502 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (541) 423-6025 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Champions Oncology today announced that it has initiated a sponsored prospective correlative trial of patient derived xenograft modeling (PDX or Champions TumorGraft PDX models) in patients with metastatic or recurrent sarcoma. Mount Sinai Hospital in Toronto, Canada is the first clinical site to enroll patients in the newly-opened study.
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that patients are being enrolled in a Phase 1 clinical trial evaluating IPI-493 in patients with advanced hematologic malignancies. This multi-center study is the second clinical trial of IPI-493, Infinity's oral heat shock protein 90 (Hsp90) chaperone inhibitor.
Nanoparticles combining platinum and gold act as superefficient catalysts, but chemists have struggled to create them in an industrially useful form. Rice University chemists have answered the call this week with a polymer-coated version of gold-platinum nanorods, the first catalysts of their kind that can be used in the organic solvents favored by chemical and drug manufacturers.
The rate of new HIV infections among blacks in South Carolina was six times higher than among all other races combined in 2006, according to new estimates released Friday by the South Carolina Department of Health and Environmental Control, the Columbia State reports.
› Verified 7 days ago
| NPI Number | 1538572201 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #15974 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 43 N Front St, Central Point, OR 97502 |
| Phone Number | 541-423-6025 |
News Archive
Champions Oncology today announced that it has initiated a sponsored prospective correlative trial of patient derived xenograft modeling (PDX or Champions TumorGraft PDX models) in patients with metastatic or recurrent sarcoma. Mount Sinai Hospital in Toronto, Canada is the first clinical site to enroll patients in the newly-opened study.
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that patients are being enrolled in a Phase 1 clinical trial evaluating IPI-493 in patients with advanced hematologic malignancies. This multi-center study is the second clinical trial of IPI-493, Infinity's oral heat shock protein 90 (Hsp90) chaperone inhibitor.
Nanoparticles combining platinum and gold act as superefficient catalysts, but chemists have struggled to create them in an industrially useful form. Rice University chemists have answered the call this week with a polymer-coated version of gold-platinum nanorods, the first catalysts of their kind that can be used in the organic solvents favored by chemical and drug manufacturers.
The rate of new HIV infections among blacks in South Carolina was six times higher than among all other races combined in 2006, according to new estimates released Friday by the South Carolina Department of Health and Environmental Control, the Columbia State reports.
› Verified 7 days ago
News Archive
Champions Oncology today announced that it has initiated a sponsored prospective correlative trial of patient derived xenograft modeling (PDX or Champions TumorGraft PDX models) in patients with metastatic or recurrent sarcoma. Mount Sinai Hospital in Toronto, Canada is the first clinical site to enroll patients in the newly-opened study.
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that patients are being enrolled in a Phase 1 clinical trial evaluating IPI-493 in patients with advanced hematologic malignancies. This multi-center study is the second clinical trial of IPI-493, Infinity's oral heat shock protein 90 (Hsp90) chaperone inhibitor.
Nanoparticles combining platinum and gold act as superefficient catalysts, but chemists have struggled to create them in an industrially useful form. Rice University chemists have answered the call this week with a polymer-coated version of gold-platinum nanorods, the first catalysts of their kind that can be used in the organic solvents favored by chemical and drug manufacturers.
The rate of new HIV infections among blacks in South Carolina was six times higher than among all other races combined in 2006, according to new estimates released Friday by the South Carolina Department of Health and Environmental Control, the Columbia State reports.
› Verified 7 days ago
Sav-on Pharmacy #3595 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1360 Plaza Blvd, Central Point, Oregon 97502 Phone: (541) 665-3766 | |
Majors Medical Supply Type: Durable Medical Equipment & Medical Supplies Supplier Location: 540 E Vilas Rd, Central Point, Oregon 97502 Phone: (541) 665-0133 | |
Numotion Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4823 Industry Dr, Central Point, Oregon 97502 Phone: (541) 772-1771 | |
Walgreens #15974 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 43 N Front St, Central Point, Oregon 97502 Phone: (541) 423-6025 |